English | Español

Regulatory
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

BioAtla cuts workforce by 70 percent amid review of business options
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Merck and Pfizer report positive phase 3 results for bladder cancer drug combination
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Novo Nordisk invests $506 million in Irish plant for oral obesity drug production
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Aardvark Therapeutics pauses Prader-Willi syndrome drug trial over cardiac safety signals
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

RFK Jr. appoints two new advisors to CDC vaccine panel before March meeting
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

UniQure faces new trial after FDA requests more data on Huntington's gene therapy

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns